| Yörük P, Dündar O, Yildizhan B, et al.
Comparison of the risk of malignancy index and self-constructed logistic regression models in preoperative evaluation of adnexal masses. [Journal Article]
J Ultrasound Med 2008 Oct; 27(10):1469-77.
Abstract | Full Citation | | Daniele L, Righi A, Ferraris A, et al.
Metastasis of Malignant Peritoneal Epithelioid Mesothelioma in Endoscopic Gastric Biopsy: A Diagnostic Pitfall. [JOURNAL ARTICLE]
Int J Surg Pathol 2008 Sep 14.
Abstract | Full Citation | Find Related Articles | | Agarwal A, Covic L, Sevigny LM, et al.
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. [Journal Article]
Mol Cancer Ther 2008 Sep; 7(9):2746-57.
Abstract | Full Citation | Find Related Articles | | Chung M, Kozuch P
Treatment of Malignant Ascites. [JOURNAL ARTICLE]
Curr Treat Options Oncol 2008 Sep 6.
Abstract | Full Citation | | Shitara K, Munakata M, Kasai M, et al.
Prolongation of Survival and Improvement in Performance Status following Palliative Chemotherapy in Gastrointestinal Cancer Patients with a Poor Performance Status. [JOURNAL ARTICLE]
Oncology 2008 Aug 20; 74(3-4):135-142.
Abstract | Full Citation | | Kesterson JP, Mhawech-Fauceglia P, Lele S
The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report. [JOURNAL ARTICLE]
Gynecol Oncol 2008 Aug 16.
Abstract | Full Citation | Find Related Articles | | Lordick F, Ott K, Weitz J, et al.
The evolving role of catumaxomab in gastric cancer. [Journal Article]
Expert Opin Biol Ther 2008 Sep; 8(9):1407-15.
Abstract | Full Citation | Find Related Articles | | Jatoi A, Giordano KF, Nguyen PL, et al.
Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group. [Journal Article]
Support Cancer Ther 2005 Oct 1; 3(1):59-62.
Full Citation | Find Related Articles | | Okawaki M, Yamaguchi Y, Okita R, et al.
Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion. [Journal Article]
Hiroshima J Med Sci 2008 Mar; 57(1):37-46.
Abstract | Full Citation | Find Related Articles | | Hamilton CA, Maxwell GL, Chernofsky MR, et al.
Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer. [JOURNAL ARTICLE]
Gynecol Oncol 2008 Jun 17.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
